Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy

Epithelioid glioblastoma is a rare aggressive variant of glioblastoma (GBM) characterized by a dismal prognosis of about 6 months and frequent leptomeningeal dissemination. A recent study has revealed that 50% of epithelioid GBMs harbor three genetic alterations – BRAF V600E mutation, TERT promoter...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Neuropathol Commun
Main Authors: Kanemaru, Yu, Natsumeda, Manabu, Okada, Masayasu, Saito, Rie, Kobayashi, Daiki, Eda, Takeyoshi, Watanabe, Jun, Saito, Shoji, Tsukamoto, Yoshihiro, Oishi, Makoto, Saito, Hirotake, Nagahashi, Masayuki, Sasaki, Takahiro, Hashizume, Rintaro, Aoyama, Hidefumi, Wakai, Toshifumi, Kakita, Akiyoshi, Fujii, Yukihiko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6659204/
https://ncbi.nlm.nih.gov/pubmed/31345255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-019-0774-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados